Login / Signup

Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern.

Karolina AkinosoglouCharalambos Gogos
Published in: Respirology (Carlton, Vic.) (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • early onset
  • rheumatoid arthritis patients
  • respiratory syndrome coronavirus
  • drug induced